title: Acute coronary syndrome upon receiving carmustine infusion before autologous stem-cell transplantation.
authors.forename: Christine
authors.initials: C
authors.lastname: Waibel Pachinger
authors.forename: Anne
authors.initials: A
authors.lastname: Rosselet
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Berthouzoz
authors.forename: François
authors.initials: F
authors.lastname: Luthi
authors.forename: Nicolas
authors.initials: N
authors.lastname: Ketterer
mesh_terms: D054058:Acute Coronary Syndrome / Q000139:chemically induced*; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D002330:Carmustine / Q000009:adverse effects*; D016543:Central Nervous System Neoplasms / Q000150:complications* / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous
chemical_list: D018906:Antineoplastic Agents, Alkylating; D002330:Carmustine